Procedure completed
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | ENVI | MÜLLER Emilia Franziska (PPE-DE) | |
Opinion | ITRE | THORS Astrid (ELDR) | |
Opinion | JURI |
Legal Basis EC Treaty (after Amsterdam) EC 095
Activites
- 2002/07/12 Final act published in Official Journal
-
2002/06/10
Final act signed
-
2002/06/10
End of procedure in Parliament
- #2429
-
2002/05/30
Council Meeting
-
2002/03/13
Decision by Parliament, 2nd reading
-
T5-0103/2002
summary
The European Parliament adopted the recommendation by Mrs Emilia MÜLLER (EPP-ED, D) subject to one amendment. (Please refer to the text dated 20/02/02).�
-
T5-0103/2002
summary
- 2002/03/12 Debate in Parliament
- 2002/02/20 Vote in committee, 2nd reading
-
2001/12/13
Committee referral announced in Parliament, 2nd reading
- #2392
-
2001/12/03
Council Meeting
-
12394/2/2001
summary
In general, the Council has followed the Commission's amended proposal. It has accepted - either in whole or in substance - the sixteen amendments adopted at first reading by the European Parliament as set out by the Commission in its amended proposal. The other European Parliament amendments which were not incorporated into the Commission's amended proposal have also been omitted by the Council. However, the idea expressed in 3 amendments according to which some vitamins and substances currently marketed but not covered in the Annex should undergo scientific evaluation, has been taken into account to some extent. The main innovations introduced by the Council relate to: 1) the setting of quantities of food supplments: Article 5 ensure a balanced approach guaranteeing both the safety of such supplements and due regard for reference intakes of the population; 2) authorisation of the placing on the market of existing food supplements not listed in Annex I or II: Article 4(6) and (7), in conjunction with Article 15 on the text's entry into force, aims to allay the concern of participants in this market by laying down clear procedures and time limits for all current supplements not listed in Annexes I or II to the text, thereby reassuring both industry and the consumer; 3) the revision of the Directive: Article 4(8) establishes an amendment procedure after a period of 5 years, which will enable the Commission usefully to take stock of the implementation of the Directive, particularly with regard to its scope, and to propose amendments if necessary. Furthermore, the Council has considered that the obligation to provide information when a product is placed on the market is ultimately the responsibility of the Member States. Lastly, it has introduced a clause providing for the possibility of the participation of the Standing Committee on Foodstuffs in order to specify the procedures for implementing Articles 7 and 8 on labelling, presentation and advertising of food supplements. The Council considers that the common position responds to a large extent to the basic wishes expressed by the European Parliament, while at the same time taking sufficient account of the concern expressed by Member States, inter alia with regard to public health and/or Community harmonisation. The Council considers that the common position achieves a good balance between the prerequisites for the proper functioning of the single market and consumer protection/information.�
-
12394/2/2001
summary
- #2371
-
2001/09/27
Council Meeting
- #2351
- 2001/05/30 Council Meeting
-
2001/03/19
Modified legislative proposal published
-
COM(2001)0159
summary
The amended proposal accepts, in total or in part, 16 of the 38 amendments proposed by the European Parliament at first reading. The Commission can accept the amendments which aim to: - specify that the ingredients of food supplements may be some substances that nutritional function (e.g. vitamins, minerals, amino acids, fatty acids) or physiological one (e.g. fibre and various plant and herbal extracts); - propose to include on the label a statement to the effect that food supplements should be stored out of reach of children; - proposes to delete Article 6(4) that would result in the vast majority of food supplements bearing in mind the statement "This is not a medicinal product". The Commission can in principle accept the amendments which aim in particular to: - underline that specific rules on vitamins and minerals laid down in the future directive should be applicable to food supplements containing vitamins, minerals and other ingredients. Otherwise it would be very easy to avoid applying these rules by adding just a small quantity of another ingredient to a food supplement containing vitamins or minerals. On the other hand, in the absence of specific Community rules concerning other ingredients relevant national rules may continue to apply, without prejudice to the provisions of the Treaty; - state in a recital that that priority should be given to the evaluation by the Scientific Committee for Food of Substances that are not included in Annex II of the proposal but which are used in the manufacture of products currently marketed in some Member States; - propose some principles for the adoption of purity criteria for vitamin preparations and mineral substances listed in Annex II; - take into account requirements of children and adults when setting maximum levels for vitamins and minerals. �
- DG [{'url': 'http://ec.europa.eu/dgs/health_consumer/index_en.htm', 'title': 'Health and Consumers'}],
-
COM(2001)0159
summary
-
2001/02/14
Decision by Parliament, 1st reading/single reading
-
T5-0079/2001
summary
The European Parliament adopted the report by Mr Emilia Franziska MÜLLER (EPP/ED, D), however, the text was subject to numerous amendments. The amendments call for: - ingredients such as amino acids, fatty acids and herbal extracts, which can also contribute to good health and are already available on the market, to be brought within the scope of the Directive; - the labelling of products covered by this Directive to always include the words 'food supplement' and the name of the category of the nutrients characterising the product and/or the ingredients characterising the product; - warnings to be carried against exceeding the recommended amount for daily consumption; if there are health risks this must be explained on then package leaflet or appear on the product itself; - products to carry warnings stating that they may be taken by pregnant women or children under the age of one only with the agreement of a doctor or health visitor; - excessive doses which could harm the user must be avoided; - certain minerals to be included in Annex I of the directive, such as boron, nickel and tin, when evidence can be provided of their usefulness in food supplements. Lastly, the Parliament calls for certain vitamin and mineral substances marketed in the EU to undergo scientific evaluation.�
-
T5-0079/2001
summary
- 2001/02/13 Debate in Parliament
- 2001/01/24 Vote in committee, 1st reading/single reading
-
2000/05/19
Committee referral announced in Parliament, 1st reading/single reading
-
2000/05/08
Legislative proposal published
-
COM(2000)0222
summary
PURPOSE : to present a Directive on the approximation of the laws of the Member States relating to food supplements. CONTENT : a wide range of products, known under the term food supplements, diet integrators or others, have been marketed in Community Member States for a number of years. The national rules applicable to them may differ substantially. This has led to obstacles to intracommunity trade that the application of the principle of mutual recognition did not succeed in overcoming. For a number of years now, there have been many comments received from Member States and other interested parties which emphasised the need to adopt Community rules on these products marketed as foodstuffs. The products in question are usually concentrated sources of nutrients and other ingredients, alone or in combination and marketed in dose form. These ingredients include, among others, vitamins, minerals, amino acids, essential fatty acids, fibre, various plant and herbal extracts. The task of covering products containing all these ingredients would be enormous and very complicated. It has therefore been decided for practical reasons to deal at this stage in detail with products containing vitamins and minerals. The measures may be amended in the future to cover in detail products containing other nutrients and/or ingredients. Furthermore, there is an important range of vitamins and mineral supplements on the market. They vary from single nutrient products of variable nutrient levels to multi-nutrient products also of variable nutrient levels for individual nutrients. Prevalence of one or the other product is determined by consumer preferences and differs from one Member State to another. Thus, the choice must be made exempt of any risks health by ensuring that products appropriate and correct information about these products through labelling. Ensuring that food is safe and providing adequate and clear information on the label have been two fundamental principles of Community food law. Another very important element regarding the safety of these products is the maximum levels of minerals they contain. These levels should therefore be stipulated in order to ensure their safety. Upper safe intake levels for some nutrients (e.g. vitamins A, D, B6 and folic acid, iron, selenium, zinc) may be close to amounts that are recommended as population reference intakes (PRI). Therefore, for these few nutrients the PRIs should be taken into account when setting maximum levels in food supplements. On the other hand, the setting of a minimum level of vitamins and minerals in these products is desirable in order to guarantee that food supplements contain a significant amount that would justify the intended purpose of the product. Once the principles for setting maximum and minimum limits have been agreed the adoption of specific limits or each nutrient, based on the opinion of the Scientific Committee for Food (SCF), is a technical matter and should be delegated to the Commission. It should be noted that excess intake of some vitamins and minerals may cause undesirable or adverse effects. Hence, the need to ensure the safety of these products which includes labelling the products with clear instructions about the use of the product, in particular the quantity to be consumed. Asit is, food supplements are excluded from the scope of Directive 90/496/EEC on nutrition labelling. Therefore, the specific relevant rules must be stipulated. These products contain hardly any significant amounts of energy, protein, carbohydrate or fat and, therefore their declaration in the nutritional labelling would be irrelevant. Their nature and intended use, however, as sources of vitamins and minerals would justify that labelling for these nutrients should be compulsory.�
- DG [{'url': 'http://ec.europa.eu/dgs/health_consumer/index_en.htm', 'title': 'Health and Consumers'}],
-
COM(2000)0222
summary
Documents
- Legislative proposal published: COM(2000)0222
- Committee report tabled for plenary, 1st reading/single reading: A5-0025/2001
- Debate in Parliament: Debate in Parliament
- Decision by Parliament, 1st reading/single reading: T5-0079/2001
- Modified legislative proposal published: COM(2001)0159
- Debate in Council: 2351
- Council position published: 12394/2/2001
- Committee recommendation tabled for plenary, 2nd reading: A5-0044/2002
- Debate in Parliament: Debate in Parliament
- Decision by Parliament, 2nd reading: T5-0103/2002
- : Directive 2002/46
- : OJ L 183 12.07.2002, p. 0051-0057
History
(these mark the time of scraping, not the official date of the change)
activities/16/docs/1/url |
Old
http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2002:183:TOCNew
http://eur-lex.europa.eu/JOHtml.do?uri=OJ:L:2002:183:SOM:EN:HTML |
links/European Commission/title |
Old
PreLexNew
EUR-Lex |
procedure/summary |
|
activities |
|
committees |
|
links |
|
other |
|
procedure |
|